Abdulkadul, Shen Milyon S.
HRN: 20-50-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
01/29/2023
02/04/2023
ORAL
3.2ml
BID
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes